EA
FMI

Emerald Advisers’s Foundation Medicine, Inc. FMI Stock Holding History

Emerald Advisers’s Portfolio FMI Stock Details FMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-18,650
Closed -$739K – 376
2013
Q3 		$739K Buy
+18,650
New +$687K 0.04% 257

Other funds holding FMI

TRV
Third Rock Ventures Boston, Massachusetts $1.07B AUM 170.23% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
PG
PEAK6 Group Chicago, Illinois $23.4B AUM 17.65% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Sandler Capital Management New York $193M AUM 77.14% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Emerald Advisers's FMI Position: Q4 2013 in Review

Emerald Advisers sold out of Foundation Medicine, Inc. (FMI) in Q4 2013, closing a stake of 18,650 shares — an estimated $739K sold.

Emerald Advisers first reported a position in FMI in Q3 2013 and held it in 1 quarter. The position peaked at $739K in Q3 2013. 85 funds tracked by Wall St. Rank hold FMI as of Q4 2013.

  • Emerald Advisers reported no remaining Foundation Medicine, Inc. position as of Q4 2013 after selling out during the quarter.
  • Emerald Advisers sold 18,650 Foundation Medicine, Inc. shares in Q4 2013, an estimated $739K.
  • Emerald Advisers first reported a position in Foundation Medicine, Inc. in Q3 2013 and held it in 1 quarter.
  • Emerald Advisers's Foundation Medicine, Inc. position peaked at $739K in Q3 2013.
  • 85 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q4 2013.

Based on Emerald Advisers's 13F filing for Q4 2013, filed 30 Jan 2014.